25 XP   0   0   10

Enfusion Inc
Buy, Hold or Sell?

Let's analyse Enfusion together

PenkeI guess you are interested in Enfusion Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Enfusion Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Enfusion Inc

I send you an email if I find something interesting about Enfusion Inc.

Quick analysis of Enfusion (30 sec.)










What can you expect buying and holding a share of Enfusion? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
42.9%

What is your share worth?

Current worth
$0.61
Expected worth in 1 year
$0.43
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
$-0.17
Return On Investment
-1.8%

For what price can you sell your share?

Current Price per Share
$9.42
Expected price per share
$7.89 - $9.962
How sure are you?
50%

1. Valuation of Enfusion (5 min.)




Live pricePrice per Share (EOD)

$9.42

Intrinsic Value Per Share

$1.40 - $1.68

Total Value Per Share

$2.01 - $2.29

2. Growth of Enfusion (5 min.)




Is Enfusion growing?

Current yearPrevious yearGrowGrow %
How rich?$77.4m$100.7m-$20.2m-25.1%

How much money is Enfusion making?

Current yearPrevious yearGrowGrow %
Making money$1.9m-$3.3m$5.2m270.6%
Net Profit Margin4.6%-9.8%--

How much money comes from the company's main activities?

3. Financial Health of Enfusion (5 min.)




What can you expect buying and holding a share of Enfusion? (5 min.)

Welcome investor! Enfusion's management wants to use your money to grow the business. In return you get a share of Enfusion.

What can you expect buying and holding a share of Enfusion?

First you should know what it really means to hold a share of Enfusion. And how you can make/lose money.

Speculation

The Price per Share of Enfusion is $9.42. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Enfusion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Enfusion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.61. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Enfusion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.1%0.010.1%-0.02-0.3%-0.23-2.4%-0.23-2.4%
Usd Book Value Change Per Share0.030.4%-0.04-0.5%-0.08-0.8%0.040.5%0.040.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.4%-0.04-0.5%-0.08-0.8%0.050.5%0.050.5%
Usd Price Per Share9.70-10.10-11.24-7.59-7.59-
Price to Earnings Ratio497.32-337.74-197.26-152.74-152.74-
Price-to-Total Gains Ratio291.70-100.68--813.88--316.35--316.35-
Price to Book Ratio15.99-16.46-12.30-9.60-9.60-
Price-to-Total Gains Ratio291.70-100.68--813.88--316.35--316.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.42
Number of shares106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.040.04
Usd Total Gains Per Share-0.040.05
Gains per Quarter (106 shares)-4.555.27
Gains per Year (106 shares)-18.1921.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-18-2831811
20-36-4653732
30-55-6485553
40-73-82117374
50-91-100139295
60-109-11816110116
70-127-13619129137
80-146-15422147158
90-164-17224165179
100-182-19027184200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%10.04.00.071.4%10.04.00.071.4%10.04.00.071.4%
Book Value Change Per Share2.02.00.050.0%6.05.01.050.0%6.06.02.042.9%6.06.02.042.9%6.06.02.042.9%
Dividend per Share0.00.04.00.0%4.00.08.033.3%6.00.08.042.9%6.00.08.042.9%6.00.08.042.9%
Total Gains per Share2.02.00.050.0%7.05.00.058.3%8.06.00.057.1%8.06.00.057.1%8.06.00.057.1%

Fundamentals of Enfusion

About Enfusion Inc

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Fundamental data was last updated by Penke on 2024-04-25 11:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Enfusion Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Enfusion earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • A Net Profit Margin of 1.3% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Enfusion Inc:

  • The MRQ is 1.3%. The company is making a profit. +1
  • The TTM is 4.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM4.6%-3.3%
TTM4.6%YOY-9.8%+14.4%
TTM4.6%5Y-66.1%+70.7%
5Y-66.1%10Y-66.1%0.0%
1.1.2. Return on Assets

Shows how efficient Enfusion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • 0.6% Return on Assets means that Enfusion generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Enfusion Inc:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM1.7%-1.2%
TTM1.7%YOY-3.2%+4.9%
TTM1.7%5Y-20.6%+22.3%
5Y-20.6%10Y-20.6%0.0%
1.1.3. Return on Equity

Shows how efficient Enfusion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • 1.2% Return on Equity means Enfusion generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Enfusion Inc:

  • The MRQ is 1.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM3.4%-2.2%
TTM3.4%YOY-6.1%+9.4%
TTM3.4%5Y-38.7%+42.1%
5Y-38.7%10Y-38.7%0.0%

1.2. Operating Efficiency of Enfusion Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Enfusion is operating .

  • Measures how much profit Enfusion makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • An Operating Margin of 4.6% means the company generated $0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Enfusion Inc:

  • The MRQ is 4.6%. The company is operating less efficient.
  • The TTM is 7.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.6%TTM7.0%-2.4%
TTM7.0%YOY-9.0%+16.0%
TTM7.0%5Y-63.4%+70.4%
5Y-63.4%10Y-63.4%0.0%
1.2.2. Operating Ratio

Measures how efficient Enfusion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Software - Application industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are $0.95 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Enfusion Inc:

  • The MRQ is 0.954. The company is less efficient in keeping operating costs low.
  • The TTM is 0.931. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.954TTM0.931+0.024
TTM0.931YOY1.090-0.160
TTM0.9315Y1.632-0.702
5Y1.63210Y1.6320.000

1.3. Liquidity of Enfusion Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Enfusion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Software - Application industry mean).
  • A Current Ratio of 3.44 means the company has $3.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Enfusion Inc:

  • The MRQ is 3.439. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.471. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.439TTM4.471-1.032
TTM4.471YOY8.476-4.005
TTM4.4715Y5.411-0.940
5Y5.41110Y5.4110.000
1.3.2. Quick Ratio

Measures if Enfusion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • A Quick Ratio of 3.14 means the company can pay off $3.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Enfusion Inc:

  • The MRQ is 3.135. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.049. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.135TTM4.049-0.914
TTM4.049YOY7.938-3.889
TTM4.0495Y4.782-0.733
5Y4.78210Y4.7820.000

1.4. Solvency of Enfusion Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Enfusion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Enfusion to Software - Application industry mean.
  • A Debt to Asset Ratio of 0.29 means that Enfusion assets are financed with 28.9% credit (debt) and the remaining percentage (100% - 28.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Enfusion Inc:

  • The MRQ is 0.289. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.246. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.246+0.043
TTM0.246YOY0.111+0.135
TTM0.2465Y1.927-1.681
5Y1.92710Y1.9270.000
1.4.2. Debt to Equity Ratio

Measures if Enfusion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Enfusion to the Software - Application industry mean.
  • A Debt to Equity ratio of 58.7% means that company has $0.59 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Enfusion Inc:

  • The MRQ is 0.587. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.488. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.587TTM0.488+0.099
TTM0.488YOY0.210+0.278
TTM0.4885Y0.211+0.277
5Y0.21110Y0.2110.000

2. Market Valuation of Enfusion Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Enfusion generates.

  • Above 15 is considered overpriced but always compare Enfusion to the Software - Application industry mean.
  • A PE ratio of 497.32 means the investor is paying $497.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Enfusion Inc:

  • The EOD is 482.964. Based on the earnings, the company is expensive. -2
  • The MRQ is 497.320. Based on the earnings, the company is expensive. -2
  • The TTM is 337.736. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD482.964MRQ497.320-14.356
MRQ497.320TTM337.736+159.583
TTM337.736YOY197.258+140.478
TTM337.7365Y152.741+184.995
5Y152.74110Y152.7410.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Enfusion Inc:

  • The EOD is 95.824. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 98.672. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 2.768. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD95.824MRQ98.672-2.848
MRQ98.672TTM2.768+95.904
TTM2.768YOY90.634-87.866
TTM2.7685Y22.177-19.409
5Y22.17710Y22.1770.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Enfusion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Software - Application industry mean).
  • A PB ratio of 15.99 means the investor is paying $15.99 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Enfusion Inc:

  • The EOD is 15.533. Based on the equity, the company is expensive. -2
  • The MRQ is 15.995. Based on the equity, the company is expensive. -2
  • The TTM is 16.457. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.533MRQ15.995-0.462
MRQ15.995TTM16.457-0.462
TTM16.457YOY12.301+4.156
TTM16.4575Y9.596+6.861
5Y9.59610Y9.5960.000
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Enfusion Inc.

3.1. Institutions holding Enfusion Inc

Institutions are holding 95.853% of the shares of Enfusion Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ICONIQ Capital, LLC15.62192.54161403959400
2023-12-31Brown Capital Management, LLC13.14961.72118176617245026.5311
2023-12-31Hillhouse Capital Advisors, Ltd.5.53590.9725497518300
2023-12-31Vanguard Group Inc4.00740.000836015191137043.26
2023-12-31Ararat Capital Management, LP2.87467.257725834152168709.164
2023-12-31BlackRock Inc2.79390.000625109271767447.572
2023-12-3112 West Capital Management LP2.11771.6423190319000
2023-12-31HHG PLC1.82010.0095163576160020.3683
2023-12-31New York State Common Retirement Fund1.80130.02171618828250.0015
2023-12-31T. Rowe Price Investment Management,Inc.0.97460.00558758418758410
2023-12-31Geode Capital Management, LLC0.86760.0008779690562677.7779
2023-12-31State Street Corporation0.76960.000369161810816618.539
2023-12-31Wasatch Advisors LP0.65680.031559031200
2023-09-30Nellore Capital Management LLC0.55720.844950074413547937.0906
2023-12-31Wellington Management Company LLP0.54450.0009489364264645.717
2023-12-31Bank of America Corp0.44820.000440282814818558.1932
2023-09-30Alyeska Investment Group, L.P.0.41730.0228375000287537328.7527
2023-12-31Next Century Growth Investors LLC0.4140.3513720683720680
2023-12-31Northern Trust Corp0.38970.0006350199176435.3053
2023-12-31Charles Schwab Investment Management Inc0.32560.0007292603117954.2004
Total 56.087515.426150406345+3277292+6.5%

3.2. Funds holding Enfusion Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Brown Capital Mgmt Small Co Inv7.06461.6639634905483157315.0716
2023-12-31Janus Henderson US Small Cap Growth1.6880.4828151705700
2023-12-31Janus Henderson Venture D1.6880.4795151705700
2024-02-29Vanguard Total Stock Mkt Idx Inv1.07950.0005970147-99800-9.3276
2024-03-28iShares Russell 2000 ETF1.07230.01369637004650.0483
2024-02-29Vanguard Small Cap Index0.8860.004979623772860.9235
2024-02-29Vanguard Information Technology ETF0.85780.008877090326738553.1034
2023-12-31T. Rowe Price Small-Cap Value0.65330.05395871005871000
2023-12-31Wasatch Micro Cap0.65270.904158658900
2023-12-31Brown Capital Small Company0.64651.942958100800
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.58570.00455264103280.0623
2024-02-29Vanguard Small Cap Growth Index Inv0.49170.01144186774531.7156
2024-01-31Fidelity Small Cap Index0.42430.012238133634040.9007
2024-03-28iShares Russell 2000 Growth ETF0.38320.0273344397-400-0.116
2024-02-29Nationwide Small Company Growth InSvc0.34031.929830586300
2023-12-31T. Rowe Price U.S. SC Value Eq Tr-Z0.29910.05282688002688000
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.26430.004923756039001.6691
2024-02-29Fidelity Extended Market Index0.22390.0046201250-975-0.4821
2024-03-29Schwab US Small-Cap ETF™0.18890.009216972300
2024-02-29Vanguard Russell 2000 ETF0.15340.0125137829106808.3996
Total 19.64357.623717653887+1887199+10.7%

3.3. Insider Transactions

Insiders are holding 8.533% of the shares of Enfusion Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-29Valeria GutowskiSELL278.73
2024-02-29Matthew CampobassoSELL1088.73
2024-01-10Deirdre SomersSELL17708.65
2024-01-08Bradley HerringSELL19989.23
2024-01-08Bronwen BastoneSELL3919.23
2024-01-08Matthew CampobassoSELL4729.23
2024-01-08Oleg MovchanSELL12959.23
2023-12-14Oleg MovchanSELL10000010.01
2023-12-01Oleg MovchanSELL15000010.09
2023-11-27Stephen MalherbeSELL10000009.86
2023-11-14Dan GromanSELL50009.97
2023-10-17Dan GromanSELL50009.09
2023-09-19Dan GromanSELL50009.07
2023-08-14Bronwen BastoneSELL417.89
2023-08-14Dan GromanSELL17607.89
2023-08-11Bronwen BastoneSELL448.1
2023-08-11Dan GromanSELL18508.1
2023-08-09Bronwen BastoneSELL558.32
2023-08-09Dan GromanSELL23178.32
2023-07-17Dan GromanSELL387711.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Enfusion Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.033-0.043+229%-0.077+330%0.043-23%0.043-23%
Book Value Per Share--0.6060.621-2%0.937-35%-0.215+135%-0.215+135%
Current Ratio--3.4394.471-23%8.476-59%5.411-36%5.411-36%
Debt To Asset Ratio--0.2890.246+17%0.111+160%1.927-85%1.927-85%
Debt To Equity Ratio--0.5870.488+20%0.210+179%0.211+179%0.211+179%
Dividend Per Share----0%-0%0.006-100%0.006-100%
Eps--0.0050.012-58%-0.024+587%-0.226+4736%-0.226+4736%
Free Cash Flow Per Share--0.0250.029-15%0.006+310%-0.002+108%-0.002+108%
Free Cash Flow To Equity Per Share--0.029-0.052+278%-0.010+134%0.027+7%0.027+7%
Gross Profit Margin---7.912-4.296-46%-0.977-88%-1.308-83%-1.308-83%
Intrinsic Value_10Y_max--1.681--------
Intrinsic Value_10Y_min--1.401--------
Intrinsic Value_1Y_max--0.038--------
Intrinsic Value_1Y_min--0.037--------
Intrinsic Value_3Y_max--0.213--------
Intrinsic Value_3Y_min--0.202--------
Intrinsic Value_5Y_max--0.509--------
Intrinsic Value_5Y_min--0.464--------
Market Cap846585799.680-46%1239320500.0001308167897.500-5%1243072326.2630%863347272.344+44%863347272.344+44%
Net Profit Margin--0.0130.046-71%-0.098+835%-0.661+5030%-0.661+5030%
Operating Margin--0.0460.070-34%-0.090+296%-0.634+1482%-0.634+1482%
Operating Ratio--0.9540.931+3%1.090-12%1.632-42%1.632-42%
Pb Ratio15.533-3%15.99516.457-3%12.301+30%9.596+67%9.596+67%
Pe Ratio482.964-3%497.320337.736+47%197.258+152%152.741+226%152.741+226%
Price Per Share9.420-3%9.70010.098-4%11.235-14%7.591+28%7.591+28%
Price To Free Cash Flow Ratio95.824-3%98.6722.768+3464%90.634+9%22.177+345%22.177+345%
Price To Total Gains Ratio283.283-3%291.703100.679+190%-813.882+379%-316.345+208%-316.345+208%
Quick Ratio--3.1354.049-23%7.938-61%4.782-34%4.782-34%
Return On Assets--0.0060.017-67%-0.032+660%-0.206+3698%-0.206+3698%
Return On Equity--0.0120.034-65%-0.061+624%-0.387+3437%-0.387+3437%
Total Gains Per Share--0.033-0.043+229%-0.077+330%0.050-33%0.050-33%
Usd Book Value--77482000.00080536750.000-4%100782000.000-23%-7494285.714+110%-7494285.714+110%
Usd Book Value Change Per Share--0.033-0.043+229%-0.077+330%0.043-23%0.043-23%
Usd Book Value Per Share--0.6060.621-2%0.937-35%-0.215+135%-0.215+135%
Usd Dividend Per Share----0%-0%0.006-100%0.006-100%
Usd Eps--0.0050.012-58%-0.024+587%-0.226+4736%-0.226+4736%
Usd Free Cash Flow--3140000.0003703000.000-15%1556250.000+102%424500.000+640%424500.000+640%
Usd Free Cash Flow Per Share--0.0250.029-15%0.006+310%-0.002+108%-0.002+108%
Usd Free Cash Flow To Equity Per Share--0.029-0.052+278%-0.010+134%0.027+7%0.027+7%
Usd Market Cap846585799.680-46%1239320500.0001308167897.500-5%1243072326.2630%863347272.344+44%863347272.344+44%
Usd Price Per Share9.420-3%9.70010.098-4%11.235-14%7.591+28%7.591+28%
Usd Profit--623000.0001943500.000-68%-3315750.000+632%-21024071.429+3475%-21024071.429+3475%
Usd Revenue--46486000.00043633750.000+7%37587250.000+24%34216357.143+36%34216357.143+36%
Usd Total Gains Per Share--0.033-0.043+229%-0.077+330%0.050-33%0.050-33%
 EOD+4 -4MRQTTM+10 -24YOY+20 -145Y+22 -1410Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of Enfusion Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15482.964
Price to Book Ratio (EOD)Between0-115.533
Net Profit Margin (MRQ)Greater than00.013
Operating Margin (MRQ)Greater than00.046
Quick Ratio (MRQ)Greater than13.135
Current Ratio (MRQ)Greater than13.439
Debt to Asset Ratio (MRQ)Less than10.289
Debt to Equity Ratio (MRQ)Less than10.587
Return on Equity (MRQ)Greater than0.150.012
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Enfusion Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.439
Ma 20Greater thanMa 509.346
Ma 50Greater thanMa 1009.142
Ma 100Greater thanMa 2009.108
OpenGreater thanClose9.140
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets108,972
Total Liabilities31,490
Total Stockholder Equity53,666
 As reported
Total Liabilities 31,490
Total Stockholder Equity+ 53,666
Total Assets = 108,972

Assets

Total Assets108,972
Total Current Assets69,852
Long-term Assets39,120
Total Current Assets
Cash And Cash Equivalents 35,604
Net Receivables 28,069
Other Current Assets 6,179
Total Current Assets  (as reported)69,852
Total Current Assets  (calculated)69,852
+/-0
Long-term Assets
Property Plant Equipment 32,618
Long-term Assets Other 6,502
Long-term Assets  (as reported)39,120
Long-term Assets  (calculated)39,120
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities20,309
Long-term Liabilities11,181
Total Stockholder Equity53,666
Total Current Liabilities
Short-term Debt 4,256
Accounts payable 2,212
Other Current Liabilities 11,443
Total Current Liabilities  (as reported)20,309
Total Current Liabilities  (calculated)17,911
+/- 2,398
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt11,181
Long-term Liabilities  (as reported)11,181
Long-term Liabilities  (calculated)11,181
+/- 0
Total Stockholder Equity
Common Stock127
Retained Earnings -172,932
Accumulated Other Comprehensive Income -406
Other Stockholders Equity 226,877
Total Stockholder Equity (as reported)53,666
Total Stockholder Equity (calculated)53,666
+/-0
Other
Capital Stock127
Cash and Short Term Investments 35,604
Common Stock Shares Outstanding 127,765
Current Deferred Revenue2,398
Liabilities and Stockholders Equity 108,972
Net Debt -20,167
Net Invested Capital 53,666
Net Working Capital 49,543
Property Plant and Equipment Gross 49,335
Short Long Term Debt Total 15,437



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
39,099
0
47,203
49,631
106,085
104,951
110,127
115,602
123,783
121,493
94,053
101,740
108,972
108,972101,74094,053121,493123,783115,602110,127104,951106,08549,63147,203039,0990
   > Total Current Assets 
28,911
28,911
34,118
34,118
35,508
89,678
86,406
90,251
96,028
96,808
86,647
59,626
62,045
69,852
69,85262,04559,62686,64796,80896,02890,25186,40689,67835,50834,11834,11828,91128,911
       Cash And Cash Equivalents 
0
13,938
0
14,515
8,432
64,365
56,206
56,559
63,543
62,545
54,598
27,771
31,652
35,604
35,60431,65227,77154,59862,54563,54356,55956,20664,3658,43214,515013,9380
       Net Receivables 
12,180
12,180
15,472
15,472
18,999
18,223
23,410
28,771
28,992
25,855
24,356
25,170
24,855
28,069
28,06924,85525,17024,35625,85528,99228,77123,41018,22318,99915,47215,47212,18012,180
       Other Current Assets 
0
2,793
0
4,131
8,077
7,090
1,332
1,287
888
2,303
2,093
1,718
1,459
6,179
6,1791,4591,7182,0932,3038881,2871,3327,0908,0774,13102,7930
   > Long-term Assets 
0
10,188
0
13,085
14,123
16,407
18,545
19,876
19,574
26,975
34,846
34,427
39,695
39,120
39,12039,69534,42734,84626,97519,57419,87618,54516,40714,12313,085010,1880
       Property Plant Equipment 
8,784
8,784
11,539
11,539
12,498
13,051
15,046
16,093
15,423
22,491
30,317
29,895
33,870
32,618
32,61833,87029,89530,31722,49115,42316,09315,04613,05112,49811,53911,5398,7848,784
       Long-term Assets Other 
0
1,404
0
1,546
1,625
3,356
3,499
3,783
4,151
4,484
4,529
4,532
5,825
6,502
6,5025,8254,5324,5294,4844,1513,7833,4993,3561,6251,54601,4040
> Total Liabilities 
0
272,658
0
278,086
279,266
8,644
8,243
10,321
12,432
20,339
22,348
21,810
28,463
31,490
31,49028,46321,81022,34820,33912,43210,3218,2438,644279,266278,0860272,6580
   > Total Current Liabilities 
10,650
10,650
12,883
12,883
16,277
8,106
7,746
9,842
11,989
17,380
13,706
13,758
16,373
20,309
20,30916,37313,75813,70617,38011,9899,8427,7468,10616,27712,88312,88310,65010,650
       Short-term Debt 
0
2,500
0
2,500
5,000
0
0
0
0
4,030
5,013
4,761
4,403
4,256
4,2564,4034,7615,0134,03000005,0002,50002,5000
       Short Long Term Debt 
0
2,500
0
2,500
5,000
0
0
0
0
0
0
0
0
0
0000000005,0002,50002,5000
       Accounts payable 
484
484
1,247
1,247
2,309
2,528
1,189
879
1,185
1,685
1,290
868
1,341
2,212
2,2121,3418681,2901,6851,1858791,1892,5282,3091,2471,247484484
       Other Current Liabilities 
709
266
848
8,288
7,932
5,578
6,557
8,963
10,804
11,665
7,403
8,129
10,629
11,443
11,44310,6298,1297,40311,66510,8048,9636,5575,5787,9328,288848266709
   > Long-term Liabilities 
0
262,008
0
265,203
262,989
538
497
479
443
2,959
8,642
8,052
12,090
11,181
11,18112,0908,0528,6422,959443479497538262,989265,2030262,0080
       Capital Lease Obligations Min Short Term Debt
0
-2,500
0
-2,500
-5,000
0
0
0
0
2,959
8,642
8,052
12,090
11,181
11,18112,0908,0528,6422,9590000-5,000-2,5000-2,5000
       Long-term Liabilities Other 
0
430
0
623
588
538
497
479
443
0
0
0
0
0
0000044347949753858862304300
       Deferred Long Term Liability 
0
0
0
0
0
1,672
0
0
0
0
0
0
0
0
000000001,67200000
> Total Stockholder Equity
0
-233,559
0
-230,883
-229,635
55,293
54,871
59,136
61,129
65,007
63,705
48,128
50,734
53,666
53,66650,73448,12863,70565,00761,12959,13654,87155,293-229,635-230,8830-233,5590
   Retained Earnings -172,932-173,555-175,383-176,012-178,863-179,357-180,896-178,474-32800000
   Accumulated Other Comprehensive Income -406-548-378-473-504-672-582-375-171,209-306-2890-2120
   Capital Surplus 
0
0
0
0
0
0
233,607
240,501
241,045
244,260
240,075
223,766
0
0
00223,766240,075244,260241,045240,501233,607000000
   Treasury Stock00000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue174,535
Cost of Revenue-57,641
Gross Profit116,894116,894
 
Operating Income (+$)
Gross Profit116,894
Operating Expense-104,946
Operating Income11,94811,948
 
Operating Expense (+$)
Research Development19,893
Selling General Administrative64,635
Selling And Marketing Expenses20,418
Operating Expense104,946104,946
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,641
Other Finance Cost-3,282
Net Interest Income1,641
 
Pretax Income (+$)
Operating Income11,948
Net Interest Income1,641
Other Non-Operating Income Expenses0
Income Before Tax (EBT)11,48412,412
EBIT - interestExpense = 10,307
8,256
7,666
Interest Expense1,641
Earnings Before Interest and Taxes (EBIT)11,94813,125
Earnings Before Interest and Taxes (EBITDA)20,535
 
After tax Income (+$)
Income Before Tax11,484
Tax Provision-1,369
Net Income From Continuing Ops9,14110,115
Net Income6,025
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses162,587
Total Other Income/Expenses Net-464-1,641
 

Technical Analysis of Enfusion
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Enfusion. The general trend of Enfusion is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Enfusion's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Enfusion Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.71 < 9.76 < 9.962.

The bearish price targets are: 9.01 > 8.12 > 7.89.

Tweet this
Enfusion Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Enfusion Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Enfusion Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Enfusion Inc. The current macd is 0.0553049.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Enfusion price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Enfusion. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Enfusion price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Enfusion Inc Daily Moving Average Convergence/Divergence (MACD) ChartEnfusion Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Enfusion Inc. The current adx is 10.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Enfusion shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Enfusion Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Enfusion Inc. The current sar is 9.76.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Enfusion Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Enfusion Inc. The current rsi is 55.44. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Enfusion Inc Daily Relative Strength Index (RSI) ChartEnfusion Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Enfusion Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Enfusion price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Enfusion Inc Daily Stochastic Oscillator ChartEnfusion Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Enfusion Inc. The current cci is -9.41780822.

Enfusion Inc Daily Commodity Channel Index (CCI) ChartEnfusion Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Enfusion Inc. The current cmo is 13.01.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Enfusion Inc Daily Chande Momentum Oscillator (CMO) ChartEnfusion Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Enfusion Inc. The current willr is -45.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Enfusion is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Enfusion Inc Daily Williams %R ChartEnfusion Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Enfusion Inc.

Enfusion Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Enfusion Inc. The current atr is 0.26757334.

Enfusion Inc Daily Average True Range (ATR) ChartEnfusion Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Enfusion Inc. The current obv is 8,254,722.

Enfusion Inc Daily On-Balance Volume (OBV) ChartEnfusion Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Enfusion Inc. The current mfi is 56.30.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Enfusion Inc Daily Money Flow Index (MFI) ChartEnfusion Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Enfusion Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Enfusion Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Enfusion Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.439
Ma 20Greater thanMa 509.346
Ma 50Greater thanMa 1009.142
Ma 100Greater thanMa 2009.108
OpenGreater thanClose9.140
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Enfusion with someone you think should read this too:
  • Are you bullish or bearish on Enfusion? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Enfusion? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Enfusion Inc

I send you an email if I find something interesting about Enfusion Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Enfusion Inc.

Receive notifications about Enfusion Inc in your mailbox!